Annual CFI
-$202.00 K
+$4.19 M+95.40%
31 December 2023
Summary:
Theriva Biologics annual cash flow from investing activities is currently -$202.00 thousand, with the most recent change of +$4.19 million (+95.40%) on 31 December 2023. During the last 3 years, it has fallen by -$193.00 thousand (-2144.44%). TOVX annual CFI is now -160.55% below its all-time high of $333.60 thousand, reached on 01 December 2000.TOVX Cash From Investing Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly CFI
$0.00
+$1000.00+100.00%
01 September 2024
Summary:
Theriva Biologics quarterly cash flow from investing activities is currently $0.00, with the most recent change of +$1000.00 (+100.00%) on 01 September 2024. Over the past year, it has increased by +$129.00 thousand (+100.00%). TOVX quarterly CFI is now -100.00% below its all-time high of $2.79 million, reached on 01 December 2011.TOVX Quarterly CFI Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
TTM CFI
-$57.00 K
+$129.00 K+69.35%
01 September 2024
Summary:
Theriva Biologics TTM cash flow from investing activities is currently -$57.00 thousand, with the most recent change of +$129.00 thousand (+69.35%) on 01 September 2024. Over the past year, it has increased by +$180.00 thousand (+75.95%). TOVX TTM CFI is now -102.05% below its all-time high of $2.78 million, reached on 01 September 2012.TOVX TTM CFI Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
TOVX Cash From Investing Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | +95.4% | +100.0% | +76.0% |
| 3 y3 years | -2144.4% | 0.0% | -307.1% |
| 5 y5 years | -100.0% | 0.0% | -100.0% |
TOVX Cash From Investing High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3 years | -2144.4% | +95.4% | +100.0% | -307.1% | +98.7% | |
| 5 y | 5 years | +95.4% | +100.0% | +98.7% | |||
| alltime | all time | -160.6% | +95.4% | -100.0% | +100.0% | -102.0% | +98.7% |
Theriva Biologics Cash From Investing History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sept 2024 | - | $0.00(-100.0%) | -$57.00 K(-69.4%) |
| June 2024 | - | -$1000.00(<-9900.0%) | -$186.00 K(-4.1%) |
| Mar 2024 | - | $0.00(-100.0%) | -$194.00 K(-4.0%) |
| Dec 2023 | -$202.00 K(-95.4%) | -$56.00 K(-56.6%) | -$202.00 K(-14.8%) |
| Sept 2023 | - | -$129.00 K(+1333.3%) | -$237.00 K(+99.2%) |
| June 2023 | - | -$9000.00(+12.5%) | -$119.00 K(-4.0%) |
| Mar 2023 | - | -$8000.00(-91.2%) | -$124.00 K(-97.2%) |
| Dec 2022 | -$4.40 M(>+9900.0%) | -$91.00 K(+727.3%) | -$4.40 M(+2.1%) |
| Sept 2022 | - | -$11.00 K(-21.4%) | -$4.30 M(+0.3%) |
| June 2022 | - | -$14.00 K(-99.7%) | -$4.29 M(+0.3%) |
| Mar 2022 | - | -$4.28 M(<-9900.0%) | -$4.28 M(>+9900.0%) |
| Dec 2021 | -$14.00 K(+55.6%) | - | - |
| Dec 2021 | - | $0.00(0.0%) | -$14.00 K(-26.3%) |
| Sept 2021 | - | $0.00(0.0%) | -$19.00 K(-17.4%) |
| June 2021 | - | $0.00(-100.0%) | -$23.00 K(0.0%) |
| Mar 2021 | - | -$14.00 K(+180.0%) | -$23.00 K(+155.6%) |
| Dec 2020 | -$9000.00(<-9900.0%) | -$5000.00(+25.0%) | -$9000.00(+125.0%) |
| Sept 2020 | - | -$4000.00(<-9900.0%) | -$4000.00(<-9900.0%) |
| June 2020 | - | $0.00(0.0%) | $0.00(0.0%) |
| Mar 2020 | - | $0.00(0.0%) | $0.00(0.0%) |
| Dec 2019 | $0.00(-100.0%) | $0.00(0.0%) | $0.00(-100.0%) |
| Sept 2019 | - | $0.00(0.0%) | -$7000.00(0.0%) |
| June 2019 | - | $0.00(0.0%) | -$7000.00(0.0%) |
| Mar 2019 | - | $0.00(-100.0%) | -$7000.00(0.0%) |
| Dec 2018 | -$7000.00(-96.7%) | -$7000.00(<-9900.0%) | -$7000.00(+133.3%) |
| Sept 2018 | - | $0.00(0.0%) | -$3000.00(-98.5%) |
| June 2018 | - | $0.00(0.0%) | -$201.00 K(0.0%) |
| Mar 2018 | - | $0.00(-100.0%) | -$201.00 K(-5.2%) |
| Dec 2017 | -$212.00 K(-62.7%) | -$3000.00(-98.5%) | -$212.00 K(-63.4%) |
| Sept 2017 | - | -$198.00 K(<-9900.0%) | -$579.00 K(+8.2%) |
| June 2017 | - | $0.00(-100.0%) | -$535.00 K(-0.2%) |
| Mar 2017 | - | -$11.00 K(-97.0%) | -$536.00 K(-5.8%) |
| Dec 2016 | -$569.00 K(+13.6%) | -$370.00 K(+140.3%) | -$569.00 K(+134.2%) |
| Sept 2016 | - | -$154.00 K(>+9900.0%) | -$243.00 K(-49.9%) |
| June 2016 | - | -$1000.00(-97.7%) | -$485.00 K(-8.0%) |
| Mar 2016 | - | -$44.00 K(0.0%) | -$527.00 K(+5.2%) |
| Dec 2015 | -$501.00 K(+943.8%) | -$44.00 K(-88.9%) | -$501.00 K(+8.4%) |
| Sept 2015 | - | -$396.00 K(+820.9%) | -$462.00 K(+425.0%) |
| June 2015 | - | -$43.00 K(+138.9%) | -$88.00 K(+41.9%) |
| Mar 2015 | - | -$18.00 K(+260.0%) | -$62.00 K(+29.2%) |
| Dec 2014 | -$48.00 K(+33.3%) | -$5000.00(-77.3%) | -$48.00 K(-11.1%) |
| Sept 2014 | - | -$22.00 K(+29.4%) | -$54.00 K(+22.7%) |
| June 2014 | - | -$17.00 K(+325.0%) | -$44.00 K(+18.9%) |
| Mar 2014 | - | -$4000.00(-63.6%) | -$37.00 K(+2.8%) |
| Dec 2013 | -$36.00 K(+260.0%) | -$11.00 K(-8.3%) | -$36.00 K(+28.6%) |
| Sept 2013 | - | -$12.00 K(+20.0%) | -$28.00 K(+21.7%) |
| June 2013 | - | -$10.00 K(+233.3%) | -$23.00 K(+76.9%) |
| Mar 2013 | - | -$3000.00(0.0%) | -$13.00 K(+30.0%) |
| Dec 2012 | -$10.00 K | -$3000.00(-57.1%) | -$10.00 K(-100.4%) |
| Sept 2012 | - | -$7000.00(<-9900.0%) | $2.78 M(-3761.8%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| June 2012 | - | $0.00(0.0%) | -$76.00 K(0.0%) |
| Mar 2012 | - | $0.00(-100.0%) | -$76.00 K(+1.3%) |
| Dec 2011 | -$75.00 K(-215.4%) | $2.79 M(-197.3%) | -$75.00 K(-97.4%) |
| Sept 2011 | - | -$2.87 M(<-9900.0%) | -$2.87 M(<-9900.0%) |
| June 2011 | - | $0.00(-100.0%) | $7200.00(-77.4%) |
| Mar 2011 | - | $1000.00(-110.6%) | $31.80 K(-51.2%) |
| Dec 2010 | $65.00 K(-137.7%) | -$9400.00(-160.3%) | $65.10 K(-10.3%) |
| Sept 2010 | - | $15.60 K(-36.6%) | $72.60 K(-152.4%) |
| June 2010 | - | $24.60 K(-28.3%) | -$138.50 K(+0.4%) |
| Mar 2010 | - | $34.30 K(-1905.3%) | -$137.90 K(-19.9%) |
| Dec 2009 | -$172.20 K(-255.3%) | -$1900.00(-99.0%) | -$172.20 K(+353.2%) |
| Sept 2009 | - | -$195.50 K(-875.8%) | -$38.00 K(-124.1%) |
| June 2009 | - | $25.20 K(>+9900.0%) | $157.50 K(+19.0%) |
| Mar 2009 | - | $0.00(-100.0%) | $132.30 K(+19.3%) |
| Dec 2008 | $110.90 K(-105.6%) | $132.30 K(>+9900.0%) | $110.90 K(-145.5%) |
| Sept 2008 | - | $0.00(0.0%) | -$243.70 K(-69.3%) |
| June 2008 | - | $0.00(-100.0%) | -$794.50 K(-59.3%) |
| Mar 2008 | - | -$21.40 K(-90.4%) | -$1.95 M(-0.8%) |
| Dec 2007 | -$1.97 M(+176.5%) | -$222.30 K(-59.6%) | -$1.97 M(-18.9%) |
| Sept 2007 | - | -$550.80 K(-52.4%) | -$2.42 M(+29.2%) |
| June 2007 | - | -$1.16 M(+3085.1%) | -$1.88 M(+151.1%) |
| Mar 2007 | - | -$36.30 K(-94.7%) | -$747.10 K(+5.1%) |
| Dec 2006 | -$710.80 K(+292.9%) | -$680.20 K(>+9900.0%) | -$710.80 K(+2222.9%) |
| Sept 2006 | - | -$3100.00(-88.7%) | -$30.60 K(+11.3%) |
| June 2006 | - | -$27.50 K(<-9900.0%) | -$27.50 K(<-9900.0%) |
| Mar 2006 | - | $0.00(-100.0%) | $0.00(-100.0%) |
| Mar 2003 | - | -$21.80 K(-85.5%) | -$171.70 K(-5.1%) |
| Dec 2002 | -$180.90 K(-468.4%) | -$149.90 K(<-9900.0%) | -$180.90 K(+49.4%) |
| Sept 2002 | - | $0.00(0.0%) | -$121.10 K(-196.0%) |
| June 2002 | - | $0.00(-100.0%) | $126.10 K(-83.5%) |
| Mar 2002 | - | -$31.00 K(-65.6%) | $765.30 K(+1455.5%) |
| Dec 2001 | $49.10 K(-85.3%) | -$90.10 K(-136.4%) | $49.20 K(-86.6%) |
| Sept 2001 | - | $247.20 K(-61.3%) | $365.80 K(+86.6%) |
| June 2001 | - | $639.20 K(-185.6%) | $196.00 K(-151.8%) |
| Mar 2001 | - | -$747.10 K(-429.8%) | -$378.60 K(-213.5%) |
| Dec 2000 | $333.60 K(-363.5%) | $226.50 K(+192.6%) | $333.60 K(+314.4%) |
| Sept 2000 | - | $77.40 K(+19.8%) | $80.50 K(-183.1%) |
| June 2000 | - | $64.60 K(-285.1%) | -$96.90 K(-38.6%) |
| Mar 2000 | - | -$34.90 K(+31.2%) | -$157.80 K(+24.6%) |
| Dec 1999 | -$126.60 K(-36.7%) | -$26.60 K(-73.4%) | -$126.60 K(+26.6%) |
| Sept 1999 | - | -$100.00 K(-2802.7%) | -$100.00 K(-66.7%) |
| June 1999 | - | $3700.00(-200.0%) | -$300.00 K(-1.2%) |
| Mar 1999 | - | -$3700.00(<-9900.0%) | -$303.70 K(+51.8%) |
| Dec 1998 | -$200.00 K(-300.0%) | $0.00(-100.0%) | -$200.00 K(-33.3%) |
| Sept 1998 | - | -$300.00 K(<-9900.0%) | -$300.00 K(-250.0%) |
| June 1998 | - | $0.00(-100.0%) | $200.00 K(0.0%) |
| Mar 1998 | - | $100.00 K(-200.0%) | $200.00 K(+100.0%) |
| Dec 1997 | $100.00 K(-150.0%) | -$100.00 K(-150.0%) | $100.00 K(-50.0%) |
| Sept 1997 | - | $200.00 K | $200.00 K |
| Dec 1996 | -$200.00 K(0.0%) | - | - |
| Dec 1994 | -$200.00 K | - | - |
FAQ
- What is Theriva Biologics annual cash flow from investing activities?
- What is the all time high annual CFI for Theriva Biologics?
- What is Theriva Biologics annual CFI year-on-year change?
- What is Theriva Biologics quarterly cash flow from investing activities?
- What is the all time high quarterly CFI for Theriva Biologics?
- What is Theriva Biologics quarterly CFI year-on-year change?
- What is Theriva Biologics TTM cash flow from investing activities?
- What is the all time high TTM CFI for Theriva Biologics?
- What is Theriva Biologics TTM CFI year-on-year change?
What is Theriva Biologics annual cash flow from investing activities?
The current annual CFI of TOVX is -$202.00 K
What is the all time high annual CFI for Theriva Biologics?
Theriva Biologics all-time high annual cash flow from investing activities is $333.60 K
What is Theriva Biologics annual CFI year-on-year change?
Over the past year, TOVX annual cash flow from investing activities has changed by +$4.19 M (+95.40%)
What is Theriva Biologics quarterly cash flow from investing activities?
The current quarterly CFI of TOVX is $0.00
What is the all time high quarterly CFI for Theriva Biologics?
Theriva Biologics all-time high quarterly cash flow from investing activities is $2.79 M
What is Theriva Biologics quarterly CFI year-on-year change?
Over the past year, TOVX quarterly cash flow from investing activities has changed by +$129.00 K (+100.00%)
What is Theriva Biologics TTM cash flow from investing activities?
The current TTM CFI of TOVX is -$57.00 K
What is the all time high TTM CFI for Theriva Biologics?
Theriva Biologics all-time high TTM cash flow from investing activities is $2.78 M
What is Theriva Biologics TTM CFI year-on-year change?
Over the past year, TOVX TTM cash flow from investing activities has changed by +$180.00 K (+75.95%)